Cargando…
Heat shock inhibits lipopolysaccharide-induced tissue factor activity in human whole blood
BACKGROUND: During gram-negative sepsis, lipopolysaccharide (LPS) induces tissue factor expression on monocytes. The resulting disseminated intravascular coagulation leads to tissue ischemia and worsens the prognosis of septic patients. There are indications, that fever reduces the mortality of seps...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034544/ https://www.ncbi.nlm.nih.gov/pubmed/17892553 http://dx.doi.org/10.1186/1477-9560-5-13 |
_version_ | 1782137018835271680 |
---|---|
author | Sucker, Christoph Zacharowski, Kai Thielmann, Matthias Hartmann, Matthias |
author_facet | Sucker, Christoph Zacharowski, Kai Thielmann, Matthias Hartmann, Matthias |
author_sort | Sucker, Christoph |
collection | PubMed |
description | BACKGROUND: During gram-negative sepsis, lipopolysaccharide (LPS) induces tissue factor expression on monocytes. The resulting disseminated intravascular coagulation leads to tissue ischemia and worsens the prognosis of septic patients. There are indications, that fever reduces the mortality of sepsis, the effect on tissue factor activity on monocytes is unknown. Therefore, we investigated whether heat shock modulates LPS-induced tissue factor activity in human blood. METHODS: Whole blood samples and leukocyte suspensions, respectively, from healthy probands (n = 12) were incubated with LPS for 2 hours under heat shock conditions (43°C) or control conditions (37°C), respectively. Subsequent to further 3 hours of incubation at 37°C the clotting time, a measure of tissue factor expression, was determined. Cell integrity was verified by trypan blue exclusion test and FACS analysis. RESULTS: Incubation of whole blood samples with LPS for 5 hours at normothermia resulted in a significant shortening of clotting time from 357 ± 108 sec to 82 ± 8 sec compared to samples incubated without LPS (n = 12; p < 0.05). This LPS effect was mediated by tissue factor, as inhibition with active site-inhibited factor VIIa (ASIS) abolished the effect of LPS on clotting time. Blockade of protein synthesis using cycloheximide demonstrated that LPS exerted its procoagulatory effect via an induction of tissue factor expression. Upon heat shock treatment, the LPS effect was blunted: clotting times were 312 ± 66 s in absence of LPS and 277 ± 65 s in presence of LPS (n = 8; p > 0.05). Similarly, heat shock treatment of leukocyte suspensions abolished the LPS-induced tissue factor activity. Clotting time was 73 ± 31 s, when cells were treated with LPS (100 ng/mL) under normothermic conditions, and 301 ± 118 s, when treated with LPS (100 ng/mL) and heat shock (n = 8, p < 0.05). Control experiments excluded cell damage as a potential cause of the observed heat shock effect. CONCLUSION: Heat shock treatment inhibits LPS-induced tissue factor activity in human whole blood samples and isolated leukocytes. |
format | Text |
id | pubmed-2034544 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-20345442007-10-19 Heat shock inhibits lipopolysaccharide-induced tissue factor activity in human whole blood Sucker, Christoph Zacharowski, Kai Thielmann, Matthias Hartmann, Matthias Thromb J Original Clinical Investigation BACKGROUND: During gram-negative sepsis, lipopolysaccharide (LPS) induces tissue factor expression on monocytes. The resulting disseminated intravascular coagulation leads to tissue ischemia and worsens the prognosis of septic patients. There are indications, that fever reduces the mortality of sepsis, the effect on tissue factor activity on monocytes is unknown. Therefore, we investigated whether heat shock modulates LPS-induced tissue factor activity in human blood. METHODS: Whole blood samples and leukocyte suspensions, respectively, from healthy probands (n = 12) were incubated with LPS for 2 hours under heat shock conditions (43°C) or control conditions (37°C), respectively. Subsequent to further 3 hours of incubation at 37°C the clotting time, a measure of tissue factor expression, was determined. Cell integrity was verified by trypan blue exclusion test and FACS analysis. RESULTS: Incubation of whole blood samples with LPS for 5 hours at normothermia resulted in a significant shortening of clotting time from 357 ± 108 sec to 82 ± 8 sec compared to samples incubated without LPS (n = 12; p < 0.05). This LPS effect was mediated by tissue factor, as inhibition with active site-inhibited factor VIIa (ASIS) abolished the effect of LPS on clotting time. Blockade of protein synthesis using cycloheximide demonstrated that LPS exerted its procoagulatory effect via an induction of tissue factor expression. Upon heat shock treatment, the LPS effect was blunted: clotting times were 312 ± 66 s in absence of LPS and 277 ± 65 s in presence of LPS (n = 8; p > 0.05). Similarly, heat shock treatment of leukocyte suspensions abolished the LPS-induced tissue factor activity. Clotting time was 73 ± 31 s, when cells were treated with LPS (100 ng/mL) under normothermic conditions, and 301 ± 118 s, when treated with LPS (100 ng/mL) and heat shock (n = 8, p < 0.05). Control experiments excluded cell damage as a potential cause of the observed heat shock effect. CONCLUSION: Heat shock treatment inhibits LPS-induced tissue factor activity in human whole blood samples and isolated leukocytes. BioMed Central 2007-09-24 /pmc/articles/PMC2034544/ /pubmed/17892553 http://dx.doi.org/10.1186/1477-9560-5-13 Text en Copyright © 2007 Sucker et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Clinical Investigation Sucker, Christoph Zacharowski, Kai Thielmann, Matthias Hartmann, Matthias Heat shock inhibits lipopolysaccharide-induced tissue factor activity in human whole blood |
title | Heat shock inhibits lipopolysaccharide-induced tissue factor activity in human whole blood |
title_full | Heat shock inhibits lipopolysaccharide-induced tissue factor activity in human whole blood |
title_fullStr | Heat shock inhibits lipopolysaccharide-induced tissue factor activity in human whole blood |
title_full_unstemmed | Heat shock inhibits lipopolysaccharide-induced tissue factor activity in human whole blood |
title_short | Heat shock inhibits lipopolysaccharide-induced tissue factor activity in human whole blood |
title_sort | heat shock inhibits lipopolysaccharide-induced tissue factor activity in human whole blood |
topic | Original Clinical Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034544/ https://www.ncbi.nlm.nih.gov/pubmed/17892553 http://dx.doi.org/10.1186/1477-9560-5-13 |
work_keys_str_mv | AT suckerchristoph heatshockinhibitslipopolysaccharideinducedtissuefactoractivityinhumanwholeblood AT zacharowskikai heatshockinhibitslipopolysaccharideinducedtissuefactoractivityinhumanwholeblood AT thielmannmatthias heatshockinhibitslipopolysaccharideinducedtissuefactoractivityinhumanwholeblood AT hartmannmatthias heatshockinhibitslipopolysaccharideinducedtissuefactoractivityinhumanwholeblood |